SOCS1-derived peptide for use in chronic complications of diabetes
The present invention relates to a SOCS1-derived peptide for use in chronic complications of diabetes, particularly ocular, renal, nerve and vascular complications, as well as compositions containing same and isolated polynucleotides encoding same. The present invention also relates to the SOCS1-der...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Fundación Instituto de Investigación Sanitaria Fundación Jiménez Díaz Fundació Hospital Universitari Vall d'Hebron-Institut de Recerca Universidad Autónoma De Madrid |
| description | The present invention relates to a SOCS1-derived peptide for use in chronic complications of diabetes, particularly ocular, renal, nerve and vascular complications, as well as compositions containing same and isolated polynucleotides encoding same. The present invention also relates to the SOCS1-derived peptide for topical use in the treatment and/or prevention of neurodegenerative diseases of the retina, particularly in the early stages of diabetic retinopathy and other diseases of the retina in which neurodegeneration plays an essential role. |
| format | Patent |
| fullrecord | <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_10532082</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10532082</sourcerecordid><originalsourceid>FETCH-uspatents_grants_105320823</originalsourceid><addsrcrecordid>eNrjZHAK9ncONtRNSS3KLEtNUShILSjJTElVSMsvUigtTlXIzFNIzijKz8tMVkjOzy3IyUxOLMnMzytWyE9TSMlMTEotSS3mYWBNS8wpTuWF0twMCm6uIc4euqXFBYklqXklxfHpRYkgytDA1NjIwMLImAglAKcyMkE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SOCS1-derived peptide for use in chronic complications of diabetes</title><source>USPTO Issued Patents</source><creator>Fundación Instituto de Investigación Sanitaria Fundación Jiménez Díaz ; Fundació Hospital Universitari Vall d'Hebron-Institut de Recerca ; Universidad Autónoma De Madrid</creator><creatorcontrib>Fundación Instituto de Investigación Sanitaria Fundación Jiménez Díaz ; Fundació Hospital Universitari Vall d'Hebron-Institut de Recerca ; Universidad Autónoma De Madrid</creatorcontrib><description>The present invention relates to a SOCS1-derived peptide for use in chronic complications of diabetes, particularly ocular, renal, nerve and vascular complications, as well as compositions containing same and isolated polynucleotides encoding same. The present invention also relates to the SOCS1-derived peptide for topical use in the treatment and/or prevention of neurodegenerative diseases of the retina, particularly in the early stages of diabetic retinopathy and other diseases of the retina in which neurodegeneration plays an essential role.</description><language>eng</language><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/10532082$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,780,802,885,64039</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/10532082$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Fundación Instituto de Investigación Sanitaria Fundación Jiménez Díaz</creatorcontrib><creatorcontrib>Fundació Hospital Universitari Vall d'Hebron-Institut de Recerca</creatorcontrib><creatorcontrib>Universidad Autónoma De Madrid</creatorcontrib><title>SOCS1-derived peptide for use in chronic complications of diabetes</title><description>The present invention relates to a SOCS1-derived peptide for use in chronic complications of diabetes, particularly ocular, renal, nerve and vascular complications, as well as compositions containing same and isolated polynucleotides encoding same. The present invention also relates to the SOCS1-derived peptide for topical use in the treatment and/or prevention of neurodegenerative diseases of the retina, particularly in the early stages of diabetic retinopathy and other diseases of the retina in which neurodegeneration plays an essential role.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNrjZHAK9ncONtRNSS3KLEtNUShILSjJTElVSMsvUigtTlXIzFNIzijKz8tMVkjOzy3IyUxOLMnMzytWyE9TSMlMTEotSS3mYWBNS8wpTuWF0twMCm6uIc4euqXFBYklqXklxfHpRYkgytDA1NjIwMLImAglAKcyMkE</recordid><startdate>20200114</startdate><enddate>20200114</enddate><creator>Fundación Instituto de Investigación Sanitaria Fundación Jiménez Díaz</creator><creator>Fundació Hospital Universitari Vall d'Hebron-Institut de Recerca</creator><creator>Universidad Autónoma De Madrid</creator><scope>EFH</scope></search><sort><creationdate>20200114</creationdate><title>SOCS1-derived peptide for use in chronic complications of diabetes</title></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_105320823</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Fundación Instituto de Investigación Sanitaria Fundación Jiménez Díaz</creatorcontrib><creatorcontrib>Fundació Hospital Universitari Vall d'Hebron-Institut de Recerca</creatorcontrib><creatorcontrib>Universidad Autónoma De Madrid</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><aucorp>Fundación Instituto de Investigación Sanitaria Fundación Jiménez Díaz</aucorp><aucorp>Fundació Hospital Universitari Vall d'Hebron-Institut de Recerca</aucorp><aucorp>Universidad Autónoma De Madrid</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SOCS1-derived peptide for use in chronic complications of diabetes</title><date>2020-01-14</date><risdate>2020</risdate><abstract>The present invention relates to a SOCS1-derived peptide for use in chronic complications of diabetes, particularly ocular, renal, nerve and vascular complications, as well as compositions containing same and isolated polynucleotides encoding same. The present invention also relates to the SOCS1-derived peptide for topical use in the treatment and/or prevention of neurodegenerative diseases of the retina, particularly in the early stages of diabetic retinopathy and other diseases of the retina in which neurodegeneration plays an essential role.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_uspatents_grants_10532082 |
| source | USPTO Issued Patents |
| title | SOCS1-derived peptide for use in chronic complications of diabetes |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T05%3A43%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.aucorp=Fundaci%C3%B3n%20Instituto%20de%20Investigaci%C3%B3n%20Sanitaria%20Fundaci%C3%B3n%20Jim%C3%A9nez%20D%C3%ADaz&rft.date=2020-01-14&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E10532082%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |